Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care
- PMID: 40443003
- PMCID: PMC12123200
- DOI: 10.18553/jmcp.2025.31.6.565
Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care
Abstract
Background: Multidisciplinary primary care models incorporating pharmacists have emerged to improve glycemic control in patients with uncontrolled type 2 diabetes mellitus (T2DM). Healthcare Effectiveness Data and Information Set (HEDIS) measures establish quality benchmarks for comprehensive diabetes care and guide reimbursement. Large-scale research on the effect of pharmacist interventions to improve these quality measures in primary care remains limited.
Objective: To evaluate the effectiveness of a pharmacist-physician collaborative care (PPCC) model on comprehensive diabetes care quality measure achievement compared with standard care (SC).
Methods: This retrospective cohort study included adults aged 18 to 75 years with uncontrolled T2DM receiving care in primary care clinics at a community-based health system in Virginia from July 1, 2018, to December 31, 2019. Patients were in one of 2 groups: (1) the intervention group (PPCC), where embedded pharmacists provided diabetes management under a collaborative practice agreement, and (2) the comparator group receiving SC in clinics without pharmacists. The SC group was created via 1:2 propensity score matching. Generalized linear mixed models assessed the association between group and quality measure achievement. Primary outcomes included glycated hemoglobin (hemoglobin A1c) (≤9%, ≤8%, ≤7%) and blood pressure control (<140/90 mm Hg), per the last recorded value in 2019.
Results: The sample (N = 1,293) had a mean age of 57 years, was 56% female, and 45% each White and Black. The PPCC group (n = 431) was more likely to achieve A1c control compared with the SC group (n = 862) (A1c <9%: odds ratio [OR] = 3.68, 95% CI = 2.31-5.84; A1c <8%: OR = 3.53, 95% CI = 2.12-5.89; A1c <7%: OR = 4.61, 95% CI = 2.48-8.56; all P < 0.01). Similarly, the PPCC group was more likely to achieve blood pressure control less than 140/90 mm Hg (OR = 1.49, 95% CI = 1.01-2.22; P = 0.04).
Conclusions: Patients in the PPCC group were more likely to meet comprehensive diabetes care quality measures compared with SC. These results underscore the value of pharmacists in diabetes management in primary care and their contribution to value-based care.
Conflict of interest statement
Drs Dixon and Salgado have received a grant from Boehringer Ingelheim for diabetes research. The other authors declare no conflicts of interest. This study was supported by the American Foundation for Pharmaceutical Education (AFPE) through 2 predoctoral training grants for Tyler D. Wagner. The content is solely the responsibility of the authors and does not necessarily represent the official views of AFPE.
Similar articles
-
Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.J Manag Care Spec Pharm. 2018 Feb;24(2):114-122. doi: 10.18553/jmcp.2018.24.2.114. J Manag Care Spec Pharm. 2018. PMID: 29384029 Free PMC article.
-
Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.J Manag Care Spec Pharm. 2017 Mar;23(3):318-326. doi: 10.18553/jmcp.2017.23.3.318. J Manag Care Spec Pharm. 2017. PMID: 28230459 Free PMC article.
-
Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.J Manag Care Spec Pharm. 2014 Sep;20(9):914-9. doi: 10.18553/jmcp.2014.20.9.914. J Manag Care Spec Pharm. 2014. PMID: 25166290 Free PMC article.
-
Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.J Manag Care Spec Pharm. 2016 May;22(5):493-515. doi: 10.18553/jmcp.2016.22.5.493. J Manag Care Spec Pharm. 2016. PMID: 27123912 Free PMC article.
-
The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007. Epub 2020 Jan 8. Prim Care Diabetes. 2020. PMID: 31926868
References
-
- Centers for Disease Control and Prevention . National Diabetes Statistic Report. CDC; 2024.
-
- Salanitro AH, Roumie CL. Blood pressure management in patients with diabetes. Clinical Diabetes . 2010;28:107-114. 10.2337/diaclin.28.3.107 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical